Matthew Davids
Associate Professor of Medicine at Dana-Farber Cancer Institute, Boston
Best podcasts with Matthew Davids
Ranked by the Snipd community
Jan 9, 2023 • 7min
CLL highlights at ASH 2022: clinical trial updates, novel BTK inhibitors & combination therapy
Leading CLL experts, Matthew Davids and Lindsey Roeker, discuss recent updates in CLL treatment, including doublet and triplet therapies, clinical trial updates, and the impact of novel BTK inhibitors. They also highlight the improvements in safety profile and progression-free survival benefit with longer follow-up of covalent BTK inhibitors in CLL treatment.
Jul 31, 2020 • 44min
The CLL Sessions: frontline therapy, BTK inhibitors, MRD negativity & novel therapies
Experts Barbara Eichhorst, Susan O’Brien, and Matthew Davids discuss frontline therapy, BTK inhibitors, MRD negativity, novel therapies, CLL14 trial updates, debulking strategies, achieving MRD negativity, triple combination therapies, sequencing in CLL treatment, non-covalent BTK inhibitors, and ongoing studies in CLL treatment.
